# Filing Detail

Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001818382-22-000019
Filing Date
2022-04-04
Accepted
2022-04-04 17:22:15
Documents
29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B7 | humacyte-424b7.htm | 424B7 | 2638677
2 |  | business10aa.jpg | GRAPHIC | 21176
3 |  | business11aa.jpg | GRAPHIC | 38193
4 |  | business12aa.jpg | GRAPHIC | 104899
5 |  | business13aa.jpg | GRAPHIC | 50671
6 |  | business14aa.jpg | GRAPHIC | 80496
7 |  | business15aa.jpg | GRAPHIC | 26521
8 |  | business16aa.jpg | GRAPHIC | 67472
9 |  | business17aa.jpg | GRAPHIC | 30408
10 |  | business18aa.jpg | GRAPHIC | 49762
11 |  | business19aa.jpg | GRAPHIC | 39979
12 |  | business1aa.jpg | GRAPHIC | 66052
13 |  | business20aa.jpg | GRAPHIC | 55127
14 |  | business21aa.jpg | GRAPHIC | 65811
15 |  | business22aa.jpg | GRAPHIC | 13690
16 |  | business23aa.jpg | GRAPHIC | 28517
17 |  | business2aa.jpg | GRAPHIC | 86127
18 |  | business3aa.jpg | GRAPHIC | 105876
19 |  | business5aa.jpg | GRAPHIC | 38952
20 |  | business6aa.jpg | GRAPHIC | 104128
21 |  | business7aa.jpg | GRAPHIC | 89220
22 |  | business8aa.jpg | GRAPHIC | 32149
23 |  | business9aa.jpg | GRAPHIC | 98853
24 |  | chart-914187e686144bbb8d6a.jpg | GRAPHIC | 37071
25 |  | chart-9564a0d3724e4c2e9aca.jpg | GRAPHIC | 34590
26 |  | chart-d5ea7498fdb14904bfca.jpg | GRAPHIC | 55603
27 |  | humacyteb.jpg | GRAPHIC | 59311
28 |  | humacytec.jpg | GRAPHIC | 15450
29 |  | tissueconstructsa.jpg | GRAPHIC | 79935
| Complete submission text file | 0001818382-22-000019.txt |  | 4813542

Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-259624 | Film No.: 22803800
SIC: 2836 Biological Products, (No Diagnostic Substances)